.png){kind=icon}
.png){kind=icon}
Return
Expanding the path to cure - a narrative review on optimizing multimodality sequencing in HCC
.png){kind=icon}
PRE
AI
H
A
E
M
V
R
J
J
P
R
P
I
L
D
G
D
DOI：10.1016/j.ctrv.2026.103194.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• HCC management is shifting toward a personalized, multimodal continuum. • TARE and SBRT are emerging as ablative options and as alternatives to TACE. • TACE combined with ICIs delays progression of unresectable HCC. • ICIs are being assessed in perioperative settings and are driving curative conversion. • Multidisciplinary teams are vital to navigate complex, modern HCC care pathways.
Journal
IF:
10.5
Papers:
2.8K
Citations:
1.3W
Organization
Cited Papers